BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 27821978)

  • 1. Gestational Trophoblastic Neoplasia: Experience from a Tertiary Care Center of India.
    Hussain A; Aziz SA; Bhatt GM; Lone AR; Hussain HI; Wani B; Qazi N
    J Obstet Gynaecol India; 2016 Dec; 66(6):404-408. PubMed ID: 27821978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of gestational trophoblastic neoplasia: experience from a tertiary cancer centre in India.
    Gulia S; Bajpai J; Gupta S; Maheshwari A; Deodhar K; Kerkar RA; Seth V; Rekhi B; Menon S
    Clin Oncol (R Coll Radiol); 2014 Jan; 26(1):39-44. PubMed ID: 24051171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic neoplasia, management as per risk stratification in a developing country.
    Hussain A; Shiekh AA; Bhat GM; Lone AR
    Indian J Med Paediatr Oncol; 2016; 37(1):28-31. PubMed ID: 27051154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
    Even C; Pautier P; Duvillard P; Floquet A; Kerbrat P; Troalen F; Rey A; Balleyguier C; Tazi Y; Leary A; Augereau P; Morice P; Droz JP; Fizazi K; Lhommé C
    Eur J Cancer; 2014 Aug; 50(12):2082-9. PubMed ID: 24910417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia.
    Aminimoghaddam S; Nezhadisalami F; Anjidani S; Barzin Tond S
    Med J Islam Repub Iran; 2018; 32():36. PubMed ID: 30159287
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5.
    Li Y; Kong Y; Wan X; Feng F; Ren T; Zhao J; Yang J; Xiang Y
    Oncologist; 2021 Dec; 26(12):e2209-e2216. PubMed ID: 34396643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical epidemiology and management of gestational trophoblastic neoplasia in Hungary in the past 34 years.
    Fülöp V; Szigetvári I; Szepesi J; Végh G; Singh M; Berkowitz RS
    J Reprod Med; 2012; 57(7-8):310-8. PubMed ID: 22838247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of drug resistant gestational trophoblastic neoplasia.
    Patel SM; Desai A
    J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk gestational trophoblastic neoplasia at Gujarat Cancer and Research Institute: thirteen years of experience.
    Chauhan A; Dave K; Desai A; Mankad M; Patel S; Dave P
    J Reprod Med; 2010; 55(7-8):333-40. PubMed ID: 20795348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
    Lurain JR; Schink JC
    J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EP-EMA) regimen.
    Mao Y; Wan X; Lv W; Xie X
    Int J Gynaecol Obstet; 2007 Jul; 98(1):44-7. PubMed ID: 17481633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory Gestational Trophoblastic Neoplasia: A Novel Drug Combination With Paclitaxel and Carboplatin Produces Durable Complete Remission.
    Rathod PS; Kundargi R; Pallavi VR; Vijay CR; Devi UK; Bafna UD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1737-41. PubMed ID: 26401644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational trophoblastic neoplasia: treatment outcomes from a single institutional experience.
    Al-Husaini H; Soudy H; Darwish A; Ahmed M; Eltigani A; Edesa W; Elhassan T; Omar A; Elghamry W; Al-Hashem H; Al-Hayli S; Madkhali I; Ahmad S; Al-Badawi IA
    Clin Transl Oncol; 2015 May; 17(5):409-15. PubMed ID: 25398721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
    Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
    J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacy of methotrexate and actinomycin D in the treatment of patients with stage I low risk gestational trophoblastic neoplasia (GTN).
    Shahbazian N; Razi T; Razi S; Yazdanpanah L
    Med J Islam Repub Iran; 2014; 28():78. PubMed ID: 25405143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EMA/CO for high-risk gestational trophoblastic neoplasia: good outcomes with induction low-dose etoposide-cisplatin and genetic analysis.
    Alifrangis C; Agarwal R; Short D; Fisher RA; Sebire NJ; Harvey R; Savage PM; Seckl MJ
    J Clin Oncol; 2013 Jan; 31(2):280-6. PubMed ID: 23233709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Jiang J; Nan FF; Yang XS; Zhang YZ; Wang B; Kong BH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptomeningeal disease as a presenting feature of gestational trophoblastic neoplasia: A review and recommendations for management.
    Hapuarachi B; Tidy JA; Romanowski C; Singh K; Gillett S; Ireson J; Winter MC
    Gynecol Oncol; 2023 May; 172():47-53. PubMed ID: 36934478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing cisplatin-based combination chemotherapy with EMA/CO chemotherapy for the treatment of high risk gestational trophoblastic neoplasia.
    Lybol C; Thomas CM; Blanken EA; Sweep FC; Verheijen RH; Westermann AM; Boere IA; Reyners AK; Massuger LF; van Hoesel RQ; Ottevanger PB
    Eur J Cancer; 2013 Mar; 49(4):860-7. PubMed ID: 23099004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.